コーパス検索結果 (１語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 endocytosis of IgG-opsonized particles, and antibody-dependent cell-mediated cytotoxicity.
2 scFv-Fc did not enhance antibody-dependent cell-mediated cytotoxicity.
3 -mediated hyperacute xenograft rejection and antibody-dependent cell-mediated cytotoxicity.
4 able to mediate complement-dependent and/or antibody-dependent cell-mediated cytotoxicity.
5 reast cancer cells in vitro and caused their antibody-dependent cell-mediated cytotoxicity.
6 induce autonomous, complement-mediated, and antibody-dependent cell-mediated cytotoxicity.
7 nding, memory B and CD4 T cell activity, and antibody-dependent cell-mediated cytotoxicity.
8 e spontaneous cell-mediated cytotoxicity and antibody-dependent cell-mediated cytotoxicity.
9 lly greater eosinophil reduction by enhanced antibody-dependent cell-mediated cytotoxicity.
10 ronger immune control of HIV-1 infection via antibody-dependent cell-mediated cytotoxicity.
11 This effect was mediated by NK-cell antibody-dependent cell-mediated cytotoxicity.
12 On NK cells, 4-1BB signaling can increase antibody-dependent cell-mediated cytotoxicity.
13 N9 virus through mechanisms likely involving antibody-dependent cell-mediated cytotoxicity.
14 odies were poor inducers and did not inhibit antibody-dependent cell-mediated cytotoxicity.
15 5 receptor alpha, inducing apoptosis through antibody-dependent cell-mediated cytotoxicity.
16 ing primarily unlicensed NK cells to mediate antibody-dependent cell-mediated cytotoxicity.
17 y, which promotes NK cell activation through antibody-dependent cell-mediated cytotoxicity.
18 g and greater than a 100-fold improvement in antibody-dependent cell-mediated cytotoxicity.
19 Thalidomide enhances rituximab-mediated, antibody-dependent, cell-mediated cytotoxicity.
20 d with their parental forms, potent in vitro antibody-dependent cell-mediated cytotoxicity (0.1-0.3 m
23 cy by palivizumab in the cotton rat and that antibody-dependent cell-mediated cytotoxicity activity c
24 as glycoengineered, which resulted in strong antibody-dependent cell-mediated cytotoxicity activity.
25 es, and generation of antibodies with potent antibody-dependent cell-mediated cytotoxicity activity.
26 l blood mononuclear cell assay, and moderate antibody-dependent, cell-mediated cytotoxicity activity
27 d followed by isotype switching for improved antibody-dependent, cell-mediated cytotoxicity activity.
28 cells and the clearance of target cells via antibody dependent cell-mediated cytotoxicity (ADCC).
29 previously generated NK cells with increased antibody-dependent cell mediated cytotoxicity (ADCC) fol
30 ubstitution provided a means to modulate the antibody-dependent cell-mediated cytotoxicity (ADCC) act
31 FcgammaRIIIa binding and function, including antibody-dependent cell-mediated cytotoxicity (ADCC) act
32 ental insights into the relationship between antibody-dependent cell-mediated cytotoxicity (ADCC) and
33 histochemistry, for affinity by BIACORE, for antibody-dependent cell-mediated cytotoxicity (ADCC) and
34 human immunodeficiency virus (HIV)-specific antibody-dependent cell-mediated cytotoxicity (ADCC) are
35 uring the killing of virus-infected cells by antibody-dependent cell-mediated cytotoxicity (ADCC) are
37 Results from serum transfer experiments and antibody-dependent cell-mediated cytotoxicity (ADCC) ass
38 to ipilimumab by multicolor flow cytometry, antibody-dependent cell-mediated cytotoxicity (ADCC) ass
40 es that enhance tumor cell susceptibility to antibody-dependent cell-mediated cytotoxicity (ADCC) by
42 evels of indirect tumor cell killing such as antibody-dependent cell-mediated cytotoxicity (ADCC) by
43 e-cell lymphoma (MCL) cell lines; effects on antibody-dependent cell-mediated cytotoxicity (ADCC) fro
44 erized by heightened cytotoxicity and potent antibody-dependent cell-mediated cytotoxicity (ADCC) fun
45 but their potential for cancer treatment via antibody-dependent cell-mediated cytotoxicity (ADCC) has
46 e chimera of this antibody (ChT-1A5) induced antibody-dependent cell-mediated cytotoxicity (ADCC) in
47 alizes nearly all HIV-1 isolates and induces antibody-dependent cell-mediated cytotoxicity (ADCC) in
48 ils cultured from mouse bone marrow produced antibody-dependent cell-mediated cytotoxicity (ADCC) in
49 novicida DeltafopC immune serum, suggesting antibody-dependent cell-mediated cytotoxicity (ADCC) in
50 variables that can influence the outcome of antibody-dependent cell-mediated cytotoxicity (ADCC) in
54 ction of a specific humoral immune response, antibody-dependent cell-mediated cytotoxicity (ADCC) may
55 te Fc gama receptors (FcgammaRs) and mediate antibody-dependent cell-mediated cytotoxicity (ADCC) may
56 odies and explains how they achieve a higher antibody-dependent cell-mediated cytotoxicity (ADCC) pot
57 been suggested, the role of non-neutralizing antibody-dependent cell-mediated cytotoxicity (ADCC) rem
58 , little is known about the neutralizing and antibody-dependent cell-mediated cytotoxicity (ADCC) res
59 ccine elicited neutralizing antibody but not antibody-dependent cell-mediated cytotoxicity (ADCC) res
60 ogenic species of Ebola viruses and elicited antibody-dependent cell-mediated cytotoxicity (ADCC) res
61 rent study, we evaluated the kinetics of the antibody-dependent cell-mediated cytotoxicity (ADCC) res
63 ion, downregulate HER3, and mediate enhanced antibody-dependent cell-mediated cytotoxicity (ADCC) via
64 oma activity by spontaneous cytotoxicity and antibody-dependent cell-mediated cytotoxicity (ADCC) whe
65 the susceptibility of HIV-infected cells to antibody-dependent cell-mediated cytotoxicity (ADCC), an
66 rituximab are not fully understood, although antibody-dependent cell-mediated cytotoxicity (ADCC), co
67 n, endowed with increased ability to mediate antibody-dependent cell-mediated cytotoxicity (ADCC), du
68 effector functions of antibodies, including antibody-dependent cell-mediated cytotoxicity (ADCC), in
69 the potency of one key protective mechanism, antibody-dependent cell-mediated cytotoxicity (ADCC), it
70 asure the killing of virus-infected cells by antibody-dependent cell-mediated cytotoxicity (ADCC), we
72 effectively targeted CML LSPCs by selective antibody-dependent cell-mediated cytotoxicity (ADCC)-fac
73 G3 antibody 3F8 kills neuroblastoma cells by antibody-dependent cell-mediated cytotoxicity (ADCC).
74 erative and antiapoptotic effects as well as antibody-dependent cell-mediated cytotoxicity (ADCC).
75 ration, and induction of cytokines enhancing antibody-dependent cell-mediated cytotoxicity (ADCC).
76 iller (NK) cells to kill tumor cells through antibody-dependent cell-mediated cytotoxicity (ADCC).
77 ls has on rat cell-mediated cytotoxicity and antibody-dependent cell-mediated cytotoxicity (ADCC).
78 complement-dependent cytotoxicity (CDC), and antibody-dependent cell-mediated cytotoxicity (ADCC).
79 type 1 (HIV-1)-infected women participate in antibody-dependent cell-mediated cytotoxicity (ADCC).
80 s initiates a mode of killing referred to as antibody-dependent cell-mediated cytotoxicity (ADCC).
81 iseased targets: (i) direct killing and (ii) antibody-dependent cell-mediated cytotoxicity (ADCC).
82 enhanced virus replication and resistance to antibody-dependent cell-mediated cytotoxicity (ADCC).
83 ic antibodies, arising in part from enhanced antibody-dependent cell-mediated cytotoxicity (ADCC).
84 ured by glycans that either promote or block antibody-dependent cell-mediated cytotoxicity (ADCC).
85 ability to eliminate virus-infected cells by antibody-dependent cell-mediated cytotoxicity (ADCC).
86 unctions of the innate immune system such as antibody-dependent cell-mediated cytotoxicity (ADCC).
87 their surface are preferentially targeted by antibody-dependent cell-mediated cytotoxicity (ADCC).
88 complement-dependent cytotoxicity (CDC) and antibody-dependent cell-mediated cytotoxicity (ADCC).
89 rum including pseudovirus neutralization and antibody-dependent cell-mediated cytotoxicity (ADCC).
90 urface can be bound by antibodies to mediate antibody-dependent cell-mediated cytotoxicity (ADCC).
91 eutralization, binding to infected cells, or antibody-dependent cell-mediated cytotoxicity (ADCC).
92 y antagonizing FGFR3 signaling and eliciting antibody-dependent cell-mediated cytotoxicity (ADCC).
93 tumor responses and tumor protection through antibody-dependent cell-mediated cytotoxicity (ADCC).
94 killer (NK) cells can kill cancer cells via antibody-dependent cell-mediated cytotoxicity (ADCC): a
98 Substantial effector functional activities (antibody-dependent cell-mediated cytotoxicity and antibo
101 ardless of specificity to infected cells for antibody-dependent cell-mediated cytotoxicity and comple
102 (hYP7 and hYP9.1b) in the IgG format induced antibody-dependent cell-mediated cytotoxicity and comple
103 The lack of effector functions, such as antibody-dependent cell-mediated cytotoxicity and comple
104 able plant-specific N-glycans and had better antibody-dependent cell-mediated cytotoxicity and effect
105 anti-neuraminidase antibodies weakly induced antibody-dependent cell-mediated cytotoxicity and enhanc
107 binding, neuraminidase inhibition, in vitro antibody-dependent cell-mediated cytotoxicity and in viv
109 e findings further suggest the importance of antibody-dependent cell-mediated cytotoxicity and/or apo
110 chanisms (complement-dependent cytotoxicity, antibody-dependent cell-mediated cytotoxicity, and antib
111 modulate human immunoglobulin G1 binding and antibody-dependent cell-mediated cytotoxicity, and may t
112 reased its binding to FcgammaRIIIa, enhanced antibody-dependent cell-mediated cytotoxicity, and more
113 TF:FVIIa-dependent intracellular signaling, antibody-dependent cell-mediated cytotoxicity, and rapid
114 nce suggest that immune mechanisms involving antibody-dependent cell-mediated cytotoxicity are prepon
115 heavy chains retain their ability to support antibody-dependent cell-mediated cytotoxicity as demonst
116 K-BR3 cells were also shown for both mAbs in antibody-dependent cell-mediated cytotoxicity assay.
117 assay, complement-mediated lysis assay, and antibody-dependent cell-mediated cytotoxicity assay.
119 e activation of natural killer (NK) cells by antibody-dependent cell-mediated cytotoxicity, both RIFI
120 associates with CD20 in lipid rafts, affects antibody-dependent cell-mediated cytotoxicity, but not c
122 feron gamma production, resulting in greater antibody-dependent cell-mediated cytotoxicity compared w
123 d optimized structure for the enhancement of antibody-dependent cell-mediated cytotoxicity, complemen
124 D16-dependent degranulation pathway, but not antibody-dependent cell-mediated cytotoxicity, contribut
125 receptor alpha that depletes eosinophils by antibody-dependent cell-mediated cytotoxicity, for patie
126 ed at ABCB5, shown to be capable of inducing antibody-dependent cell-mediated cytotoxicity in ABCB5+
127 In addition, SEFL variants demonstrated no antibody-dependent cell-mediated cytotoxicity in vitro a
128 odies displayed cellular phagocytosis and/or antibody-dependent cell-mediated cytotoxicity in vitro O
129 outbreak variants of Ebola virus and mediate antibody-dependent cell-mediated cytotoxicity in vitro.
130 cgammaRIIB molecule is a potent regulator of antibody-dependent cell-mediated cytotoxicity in vivo, m
131 ce deficient in FcgammaRIIB showed much more antibody-dependent cell-mediated cytotoxicity; in contra
132 ased in vivo tumor cell clearance, NKG2D- or antibody-dependent cell-mediated cytotoxicity-induced tu
133 ch combines potent signaling inhibition with antibody-dependent cell-mediated cytotoxicity induction
134 ying specificities regulate the magnitude of antibody-dependent cell-mediated cytotoxicity induction.
135 ging Microscopy in Nanowell Grids to analyze antibody-dependent cell-mediated cytotoxicity kinetics o
136 e.g., antagonism of growth factor receptors, antibody-dependent cell-mediated cytotoxicity) limit eff
137 izing antibody-dependent mechanisms, such as antibody-dependent cell-mediated cytotoxicity, may be in
138 ing antibodies, neutralising antibodies, and antibody-dependent cell-mediated cytotoxicity measured 2
139 N9) vaccines elicited robust, cross-reactive antibody-dependent cell-mediated cytotoxicity-mediating
141 gnificantly lesser extent, IMC-NC7 initiated antibody-dependent cell-mediated cytotoxicity on FLT3-ex
142 ween milk or plasma neutralization activity, antibody-dependent cell-mediated cytotoxicity, or HIV-1
143 eptor affinity maturation and defects in the antibody-dependent cell-mediated cytotoxicity pathway.
147 cell leukemia virus (HTLV)-specific envelope antibody-dependent cell-mediated cytotoxicity responses,
148 ticular the IgG1 and IgG3 subclass mediating antibody-dependent cell-mediated cytotoxicity, seem to p
150 role in patients undergoing mAb therapy via antibody-dependent cell-mediated cytotoxicity, thus expl
151 reactive antibodies were capable of inducing antibody-dependent cell-mediated cytotoxicity to autolog
152 hu14.18 has been shown to elicit a level of antibody-dependent cell-mediated cytotoxicity toward hum
153 ations in the MICA and MICB genes related to antibody-dependent cell-mediated cytotoxicity were ident
154 and engagement of myeloid effector cells for antibody-dependent cell-mediated cytotoxicity, were simi
155 of NMO patient serum reduced by >95% CDC and antibody-dependent cell-mediated cytotoxicity, without i